Atlas Trials

Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery

Clinical trial NCT01344226 · COMPLETED

Trial details

NCT number
NCT01344226
Sponsor
Toyos Clinic
Status
COMPLETED
Study type
OBSERVATIONAL
PseudophakiaInflammation
Start date
2011-04-01
Primary completion
2013-09-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.